Analystreport

X4 Pharmaceuticals (NASDAQ:XFOR) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

X4 Pharmaceuticals, Inc.  (XFOR) 
Last x4 pharmaceuticals, inc. earnings: 3/12 07:30 am Check Earnings Report